Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Working Capital/Sales

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   Working Capital/Sales(x) 1.121.080.991.026.37

What is the latest Working Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Working Capital/Sales ratio of NATH BIOGENES (INDIA) is 1.12 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.12
Mar20241.08
Mar20230.99
Mar20221.02
Mar20136.37

How is Working Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2025 1.12
3.70
Mar2024 1.08
9.09
Mar2023 0.99
-2.94
Mar2022 1.02
-83.99
Mar2013 6.37 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Working Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹315.6 Cr -2.3% -2.1% -11.7% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,184.8 Cr -2.5% 3.3% -28.6% Stock Analytics
KAVERI SEED COMPANY ₹5,277.1 Cr -5.5% -8.1% 7.7% Stock Analytics
VENKYS (INDIA) ₹1,877.7 Cr -13.2% -10.3% -25.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,236.5 Cr -1.6% -3.3% -24.5% Stock Analytics
INDO US BIOTECH ₹268.9 Cr -3.5% -0.4% -51.9% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.3%

-2.1%

-11.7%

SENSEX

1.2%

2.8%

6.3%


You may also like the below Video Courses